China Pharmaceuticals and Healthcare Report Q2 2015

BMI Research
April 1, 2015
198 Pages - SKU: BMI5478798
Countries covered: China

China Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Pharmaceutical sales in China will continue to grow robustly - boosted by the improvement inhealthcare access, liberalisation of the industry as well as an epidemiological transition towards chronicdiseases. This will present strong revenue earning opportunities for both domestic and multinationalpharmaceutical companies. However, downside risks to this upbeat outlook remain as the government willface pressures to contain medicine costs.

Headline Expenditure Projections

Pharmaceuticals: CNY608.45bn (USD98.75bn) in 2014 to CNY686.69bn (USD110.26bn) by 2015;+12.9% in local currency terms and +11.7% in USD terms.

Healthcare: CNY3,729.07bn (USD605.22bn) in 2014 to CNY4,276.73bn (USD686.72bn) in 2015;+14.7% in local currency and +13.5% in USD terms.



More Prescription Drugs reports by BMI Research

Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015BMI View: Zimbabwe's Treasury has failed to assign sufficient funds to the health sector in its 2015 National Budget, ...
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015BMI View: The ageing population will have an unprecedented impact on the demand of healthcare and therapeutics in ...
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015BMI View: Access to healthcare in Sudan and South Sudan is poor and drug shortages are ...
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015BMI View: Sri Lanka's strong pharmaceutical market is backed by a committed government and plans to deliver improved ...
See all reports like this >>

More China Prescription Drugs reports

Pharmaceuticals Markets in China by Asia Market Information & Development Company
Pharmaceuticals Markets in ChinaChina's demand for Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production ...
Osteoporosis Drugs Markets in China by Asia Market Information & Development Company
Osteoporosis Drugs Markets in ChinaChina's demand for Osteoporosis Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
Mental Illness Drugs Markets in China by Asia Market Information & Development Company
Mental Illness Drugs Markets in ChinaChina's demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next decade, ...
Hypertension Drugs Markets in China by Asia Market Information & Development Company
Hypertension Drugs Markets in ChinaChina's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!